EurekaMag.com logo
+ Site Statistics
References:
53,623,987
Abstracts:
29,492,080
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Multicenter study of lisinopril pharmacokinetics in hypertensive children and infants



Multicenter study of lisinopril pharmacokinetics in hypertensive children and infants



Pediatric Research 51(4 Part 2): 431A, April




(PDF 0-2 workdays service: $29.90)

Accession: 035349934

Download citation: RISBibTeXText



Related references

Lisinopril pharmacokinetics in hypertensive children and infants. American Journal of Hypertension 15(4 Part 2): 46A, April, 2002

Multicenter study of enalapril pharmacokinetics in hypertensive children and infants. Pediatric Research 47(4 Part 2): 473A, April, 2000

A multicenter study of the pharmacokinetics of lisinopril in pediatric patients with hypertension. Pediatric Nephrology 22(5): 695-701, 2007

Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants. Pathologie-Biologie 34(5): 525-529, 1986

A multicenter study to evaluate the efficacy and safety of lisinopril in hypertensive patients with impaired renal function. American Journal of Hypertension 7(4 PART 2): 127A, 1994

The antihypertensive effects of the lisinopril-hydrochlorothiazide combination (Zestoretic) in elderly hypertensive patients. The results of a multicenter study. The Italian Zestoretic Study Group. Minerva Cardioangiologica 42(10): 483-491, 1994

The population pharmacokinetics of lisinopril in hypertensive patients. British Journal of Clinical Pharmacology 26(5): 618P-619P, 1988

Population pharmacokinetics of lisinopril in hypertensive patients. Gerontology 33 Suppl 1: 17-23, 1987

Pharmacokinetics of enalapril in hypertensive children and infants. American Journal of Hypertension 13(4 Part 2): 126A, April, 2000

Losartan and E-3174 pharmacokinetics in hypertensive children and infants. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 149A, September, 2002

Antihypertensive effectiveness of low-dose lisinopril-hydrochlorothiazide combination. A large multicenter study. Lisinopril-Hydrochlorothiazide Group. Archives of Internal Medicine 154(7): 737-743, 1994

Controlled multicenter study of the antihypertensive effects of lisinopril, hydrochlorothiazide, and lisinopril plus hydrochlorothiazide in the treatment of 394 patients with mild to moderate essential hypertension. Journal of Cardiovascular Pharmacology 9 Suppl 3: S36-S42, 1987

Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal function. European Journal of Clinical Pharmacology 34(1): 61-66, 1988

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: A multicenter placebo-controlled trial. Hypertension (Dallas) 30(1 PART 1): 140-145, 1997

Lisinopril versus hydrochlorothiazide in obese hypertensive patients: a multicenter placebo-controlled trial. Treatment in Obese Patients With Hypertension (TROPHY) Study Group. Hypertension 30(1 Pt 1): 140-145, 1997